United States Radiopharmaceutical Market Report 2018

June 2018 | 110 pages | ID: U641A4FC48FEN
QYResearch

Abstracts

In this report, the United States Radiopharmaceutical market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Radiopharmaceutical in these regions, from 2013 to 2025 (forecast).

United States Radiopharmaceutical market competition by top manufacturers/players, with Radiopharmaceutical sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bracco Imaging
• Bayer
• Mallinckrodt
• Nordion
• Triad Isotopes
• Lantheus
• IBA Group
• GE Healthcare
• China Isotope & Radiation
• Jubilant Pharma
• Eli Lilly
• Advanced Accelerator Applications
• SIEMENS
• Dongcheng
• Navidea

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Actinium-225
• Lutetium-177
• Radium-223
• Holmium-166
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Oncology
• Cardiology
• Other

Contents

United States Radiopharmaceutical Market Report 2018

1 RADIOPHARMACEUTICAL OVERVIEW

1.1 Product Overview and Scope of Radiopharmaceutical
1.2 Classification of Radiopharmaceutical by Product Category
  1.2.1 United States Radiopharmaceutical Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Radiopharmaceutical Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Actinium-225
  1.2.4 Lutetium-177
  1.2.5 Radium-223
  1.2.6 Holmium-166
  1.2.7 Other
1.3 United States Radiopharmaceutical Market by Application/End Users
  1.3.1 United States Radiopharmaceutical Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Oncology
  1.3.3 Cardiology
  1.3.4 Other
1.4 United States Radiopharmaceutical Market by Region
  1.4.1 United States Radiopharmaceutical Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Radiopharmaceutical Status and Prospect (2013-2025)
  1.4.3 Southwest Radiopharmaceutical Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Radiopharmaceutical Status and Prospect (2013-2025)
  1.4.5 New England Radiopharmaceutical Status and Prospect (2013-2025)
  1.4.6 The South Radiopharmaceutical Status and Prospect (2013-2025)
  1.4.7 The Midwest Radiopharmaceutical Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Radiopharmaceutical (2013-2025)
  1.5.1 United States Radiopharmaceutical Sales and Growth Rate (2013-2025)
  1.5.2 United States Radiopharmaceutical Revenue and Growth Rate (2013-2025)

2 UNITED STATES RADIOPHARMACEUTICAL MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Radiopharmaceutical Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Radiopharmaceutical Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Radiopharmaceutical Average Price by Players/Suppliers (2013-2018)
2.4 United States Radiopharmaceutical Market Competitive Situation and Trends
  2.4.1 United States Radiopharmaceutical Market Concentration Rate
  2.4.2 United States Radiopharmaceutical Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Radiopharmaceutical Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES RADIOPHARMACEUTICAL SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Radiopharmaceutical Sales and Market Share by Region (2013-2018)
3.2 United States Radiopharmaceutical Revenue and Market Share by Region (2013-2018)
3.3 United States Radiopharmaceutical Price by Region (2013-2018)

4 UNITED STATES RADIOPHARMACEUTICAL SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Radiopharmaceutical Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Radiopharmaceutical Revenue and Market Share by Type (2013-2018)
4.3 United States Radiopharmaceutical Price by Type (2013-2018)
4.4 United States Radiopharmaceutical Sales Growth Rate by Type (2013-2018)

5 UNITED STATES RADIOPHARMACEUTICAL SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Radiopharmaceutical Sales and Market Share by Application (2013-2018)
5.2 United States Radiopharmaceutical Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES RADIOPHARMACEUTICAL PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bracco Imaging
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Radiopharmaceutical Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.2 Radiopharmaceutical Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Mallinckrodt
  6.3.2 Radiopharmaceutical Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Nordion
  6.4.2 Radiopharmaceutical Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Triad Isotopes
  6.5.2 Radiopharmaceutical Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Lantheus
  6.6.2 Radiopharmaceutical Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 IBA Group
  6.7.2 Radiopharmaceutical Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 GE Healthcare
  6.8.2 Radiopharmaceutical Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 China Isotope & Radiation
  6.9.2 Radiopharmaceutical Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Jubilant Pharma
  6.10.2 Radiopharmaceutical Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Eli Lilly
6.12 Advanced Accelerator Applications
6.13 SIEMENS
6.14 Dongcheng
6.15 Navidea

7 RADIOPHARMACEUTICAL MANUFACTURING COST ANALYSIS

7.1 Radiopharmaceutical Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Radiopharmaceutical

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Radiopharmaceutical Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Radiopharmaceutical Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES RADIOPHARMACEUTICAL MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Radiopharmaceutical Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Radiopharmaceutical Sales Volume Forecast by Type (2018-2025)
11.3 United States Radiopharmaceutical Sales Volume Forecast by Application (2018-2025)
11.4 United States Radiopharmaceutical Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Radiopharmaceutical
Figure United States Radiopharmaceutical Market Size (M Doses) by Type (2013-2025)
Figure United States Radiopharmaceutical Sales Volume Market Share by Type (Product Category) in 2017
Figure Actinium-225 Product Picture
Figure Lutetium-177 Product Picture
Figure Radium-223 Product Picture
Figure Holmium-166 Product Picture
Figure Other Product Picture
Figure United States Radiopharmaceutical Market Size (M Doses) by Application (2013-2025)
Figure United States Sales Market Share of Radiopharmaceutical by Application in 2017
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Radiopharmaceutical Market Size (Million USD) by Region (2013-2025)
Figure The West Radiopharmaceutical Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Radiopharmaceutical Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Radiopharmaceutical Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Radiopharmaceutical Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Radiopharmaceutical Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Radiopharmaceutical Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Radiopharmaceutical Sales (M Doses) and Growth Rate (2013-2025)
Figure United States Radiopharmaceutical Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Radiopharmaceutical Market Major Players Product Sales Volume (M Doses) (2013-2018)
Table United States Radiopharmaceutical Sales (M Doses) of Key Players/Suppliers (2013-2018)
Table United States Radiopharmaceutical Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Radiopharmaceutical Sales Share by Players/Suppliers
Figure 2017 United States Radiopharmaceutical Sales Share by Players/Suppliers
Figure United States Radiopharmaceutical Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Radiopharmaceutical Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Radiopharmaceutical Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Radiopharmaceutical Revenue Share by Players/Suppliers
Figure 2017 United States Radiopharmaceutical Revenue Share by Players/Suppliers
Table United States Market Radiopharmaceutical Average Price (USD/Dose) of Key Players/Suppliers (2013-2018)
Figure United States Market Radiopharmaceutical Average Price (USD/Dose) of Key Players/Suppliers in 2017
Figure United States Radiopharmaceutical Market Share of Top 3 Players/Suppliers
Figure United States Radiopharmaceutical Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Radiopharmaceutical Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Radiopharmaceutical Product Category
Table United States Radiopharmaceutical Sales (M Doses) by Region (2013-2018)
Table United States Radiopharmaceutical Sales Share by Region (2013-2018)
Figure United States Radiopharmaceutical Sales Share by Region (2013-2018)
Figure United States Radiopharmaceutical Sales Market Share by Region in 2017
Table United States Radiopharmaceutical Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Radiopharmaceutical Revenue Share by Region (2013-2018)
Figure United States Radiopharmaceutical Revenue Market Share by Region (2013-2018)
Figure United States Radiopharmaceutical Revenue Market Share by Region in 2017
Table United States Radiopharmaceutical Price (USD/Dose) by Region (2013-2018)
Table United States Radiopharmaceutical Sales (M Doses) by Type (2013-2018)
Table United States Radiopharmaceutical Sales Share by Type (2013-2018)
Figure United States Radiopharmaceutical Sales Share by Type (2013-2018)
Figure United States Radiopharmaceutical Sales Market Share by Type in 2017
Table United States Radiopharmaceutical Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Radiopharmaceutical Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Radiopharmaceutical by Type (2013-2018)
Figure Revenue Market Share of Radiopharmaceutical by Type in 2017
Table United States Radiopharmaceutical Price (USD/Dose) by Types (2013-2018)
Figure United States Radiopharmaceutical Sales Growth Rate by Type (2013-2018)
Table United States Radiopharmaceutical Sales (M Doses) by Application (2013-2018)
Table United States Radiopharmaceutical Sales Market Share by Application (2013-2018)
Figure United States Radiopharmaceutical Sales Market Share by Application (2013-2018)
Figure United States Radiopharmaceutical Sales Market Share by Application in 2017
Table United States Radiopharmaceutical Sales Growth Rate by Application (2013-2018)
Figure United States Radiopharmaceutical Sales Growth Rate by Application (2013-2018)
Table Bracco Imaging Basic Information List
Table Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bracco Imaging Radiopharmaceutical Sales Growth Rate (2013-2018)
Figure Bracco Imaging Radiopharmaceutical Sales Market Share in United States (2013-2018)
Figure Bracco Imaging Radiopharmaceutical Revenue Market Share in United States (2013-2018)
Table Bayer Basic Information List
Table Bayer Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bayer Radiopharmaceutical Sales Growth Rate (2013-2018)
Figure Bayer Radiopharmaceutical Sales Market Share in United States (2013-2018)
Figure Bayer Radiopharmaceutical Revenue Market Share in United States (2013-2018)
Table Mallinckrodt Basic Information List
Table Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Mallinckrodt Radiopharmaceutical Sales Growth Rate (2013-2018)
Figure Mallinckrodt Radiopharmaceutical Sales Market Share in United States (2013-2018)
Figure Mallinckrodt Radiopharmaceutical Revenue Market Share in United States (2013-2018)
Table Nordion Basic Information List
Table Nordion Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Nordion Radiopharmaceutical Sales Growth Rate (2013-2018)
Figure Nordion Radiopharmaceutical Sales Market Share in United States (2013-2018)
Figure Nordion Radiopharmaceutical Revenue Market Share in United States (2013-2018)
Table Triad Isotopes Basic Information List
Table Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Triad Isotopes Radiopharmaceutical Sales Growth Rate (2013-2018)
Figure Triad Isotopes Radiopharmaceutical Sales Market Share in United States (2013-2018)
Figure Triad Isotopes Radiopharmaceutical Revenue Market Share in United States (2013-2018)
Table Lantheus Basic Information List
Table Lantheus Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Lantheus Radiopharmaceutical Sales Growth Rate (2013-2018)
Figure Lantheus Radiopharmaceutical Sales Market Share in United States (2013-2018)
Figure Lantheus Radiopharmaceutical Revenue Market Share in United States (2013-2018)
Table IBA Group Basic Information List
Table IBA Group Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure IBA Group Radiopharmaceutical Sales Growth Rate (2013-2018)
Figure IBA Group Radiopharmaceutical Sales Market Share in United States (2013-2018)
Figure IBA Group Radiopharmaceutical Revenue Market Share in United States (2013-2018)
Table GE Healthcare Basic Information List
Table GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GE Healthcare Radiopharmaceutical Sales Growth Rate (2013-2018)
Figure GE Healthcare Radiopharmaceutical Sales Market Share in United States (2013-2018)
Figure GE Healthcare Radiopharmaceutical Revenue Market Share in United States (2013-2018)
Table China Isotope & Radiation Basic Information List
Table China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure China Isotope & Radiation Radiopharmaceutical Sales Growth Rate (2013-2018)
Figure China Isotope & Radiation Radiopharmaceutical Sales Market Share in United States (2013-2018)
Figure China Isotope & Radiation Radiopharmaceutical Revenue Market Share in United States (2013-2018)
Table Jubilant Pharma Basic Information List
Table Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Jubilant Pharma Radiopharmaceutical Sales Growth Rate (2013-2018)
Figure Jubilant Pharma Radiopharmaceutical Sales Market Share in United States (2013-2018)
Figure Jubilant Pharma Radiopharmaceutical Revenue Market Share in United States (2013-2018)
Table Eli Lilly Basic Information List
Table Advanced Accelerator Applications Basic Information List
Table SIEMENS Basic Information List
Table Dongcheng Basic Information List
Table Navidea Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Radiopharmaceutical
Figure Manufacturing Process Analysis of Radiopharmaceutical
Figure Radiopharmaceutical Industrial Chain Analysis
Table Raw Materials Sources of Radiopharmaceutical Major Players/Suppliers in 2017
Table Major Buyers of Radiopharmaceutical
Table Distributors/Traders List
Figure United States Radiopharmaceutical Sales Volume (M Doses) and Growth Rate Forecast (2018-2025)
Figure United States Radiopharmaceutical Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Radiopharmaceutical Price (USD/Dose) Trend Forecast (2018-2025)
Table United States Radiopharmaceutical Sales Volume (M Doses) Forecast by Type (2018-2025)
Figure United States Radiopharmaceutical Sales Volume (M Doses) Forecast by Type (2018-2025)
Figure United States Radiopharmaceutical Sales Volume (M Doses) Forecast by Type in 2025
Table United States Radiopharmaceutical Sales Volume (M Doses) Forecast by Application (2018-2025)
Figure United States Radiopharmaceutical Sales Volume (M Doses) Forecast by Application (2018-2025)
Figure United States Radiopharmaceutical Sales Volume (M Doses) Forecast by Application in 2025
Table United States Radiopharmaceutical Sales Volume (M Doses) Forecast by Region (2018-2025)
Table United States Radiopharmaceutical Sales Volume Share Forecast by Region (2018-2025)
Figure United States Radiopharmaceutical Sales Volume Share Forecast by Region (2018-2025)
Figure United States Radiopharmaceutical Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources